Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P190024/S015

CINtec PLUS Cytology

Ventana Medical Systems, Inc. · Decision date Sep 4, 2025

FDA DECISIONP190024/S015

What did the FDA decide?

FDA records P190024/S015 as a supplement to PMA P190024, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Sep 4, 2025.

FDA approval order statement

approval for the addition of two new suppliers for two different raw materials
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Pathology
Decision date
Sep 4, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P190024/S015
Regulatory pathway
PMA supplement
Product code
QKF
Decision code
OK30
Decision date
Sep 4, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Immunocytochemistry assay, p16/Ki-67.

Product code
QKF
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P190024/S015 received

    Application receipt date recorded by FDA.

  2. P190024/S015 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P190024. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P190024

Product / regulatory recordCompanyPathwayDecision dateSource
Ventana Medical Systems, Inc.PMA supplementJul 31, 2025FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Ventana Medical Systems, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1910 E. Innovation Park Dr., Tucson, AZ, 85755

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records